| 000 | 01402cam a2200361 a 4500 | ||
|---|---|---|---|
| 005 | 20250918140433.0 | ||
| 008 | 110419s2010 enka b 001 0 eng | ||
| 020 | _a9781849730457 (set) RM1032.46 | ||
| 020 | _a1849730458 (set) | ||
| 020 | _a9781849730631 (hbk. : v. 1) | ||
| 020 | _a1849730636 (hbk. : v. 1) | ||
| 020 | _a9781849730648 (hbk. : v. 2) | ||
| 020 | _a1849730644 (hbk. : v. 2) | ||
| 039 | 9 |
_a201108011244 _bzainol _c201106101538 _drazalis _y04-19-2011 _zrazalis |
|
| 040 | _aUKM | ||
| 060 |
_aWT155 _b.E53 2010 9 |
||
| 090 | _aWT155.E53 2010 9 | ||
| 245 | 0 | 0 |
_aEmerging drugs and targets for Alzheimer's disease / _cedited by Ana Martinez |
| 260 |
_aCambridge : _bRoyal Society of Chemistry, _c2010 |
||
| 300 |
_a2 v. : _bill. ; _c24 cm. |
||
| 490 | 1 |
_aRSC drug discovery series, _x2041-3203 ; _vv. 2-3 |
|
| 505 | 0 | _av. 1. Beta-amyloid, tau protein, and glucose metabolism -- v. 2. Neuronal plasticity, neuronal protection, and other miscellaneous strategies. | |
| 650 | 2 |
_aAlzheimer Disease _xdrug therapy |
|
| 650 | 2 | _aDrug delivery systems | |
| 700 | 1 |
_aMartinez, Ana, _d1961- |
|
| 710 | 2 | _aRoyal Society of Chemistry (Great Britain) | |
| 907 |
_a.b15005537 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kWT155.E53 2010 9 |
||
| 914 | _avtls003462752 | ||
| 991 | _aJabatan Farmasi, KKL | ||
| 998 |
_ad _b2011-06-04 _cm _da _feng _genk _y0 _z.b15005537 |
||
| 999 |
_c485316 _d485316 |
||